Drug interactions
Idarubicin + Sipuleucel-t
Severity: Moderate
Idarubicin and Sipuleucel-t: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Idarubicin is myelosuppressive and immunosuppressive, which may impair the immune response that sipuleucel-T relies on. Efficacy of the immunotherapy may be reduced.
What this interaction means in plain words
Idarubicin and Sipuleucel-t can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Cytotoxic immunosuppression may blunt immune activation by sipuleucel-T.
What to do
Avoid chemotherapy around leukapheresis and infusion where possible. Plan the sequence with the oncology team.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Idarubicin and Sipuleucel-t, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Idarubicin
- Adenovirus types 4 and 7 live + Idarubicin Contraindicated
- Belatacept + Idarubicin Major
- Cyclophosphamide + Idarubicin Major
- Deferiprone + Idarubicin Major
- Dengue vaccine + Idarubicin Major
- Etrasimod + Idarubicin Major
Frequently asked questions
Can I take Idarubicin with Sipuleucel-t?
MediHelp rates the interaction as moderate. Idarubicin and Sipuleucel-t can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Idarubicin is myelosuppressive and immunosuppressive, which may impair the immune response that sipuleucel-T relies on. Efficacy of the immunotherapy may be reduced.
How serious is the interaction between Idarubicin and Sipuleucel-t?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid chemotherapy around leukapheresis and infusion where possible. Plan the sequence with the oncology team.
What other medicines interact with Idarubicin?
MediHelp also lists interactions of Idarubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclophosphamide. The full list is on the Idarubicin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
